Journal article icon

Journal article

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all cause mortality

Abstract:

Objective
Experimental evidence has shown potential cardioprotective actions of phosphodiesterase type-5 inhibitors (PDE5is). We investigated whether phosphodiesterase type-5 inhibitor (PDE5i) use in patients with type 2 diabetes, with high attendant cardiovascular risk, was associated with altered mortality in a retrospective cohort study.

Research Design and Methods
Between January 2007 and May 2015, 5,956 men aged 40-89 years diagnosed with type 2 diabetes before 200...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, Oxford Martin School
More by this author
Institution:
University of Oxford
Department:
Oxford, Oxford Martin School
More by this author
Institution:
University of Oxford
Department:
Oxford, Oxford Martin School
Hutchings, DC More by this author
Rutter, MK More by this author
Expand authors...
More from this funder
Funding agency for:
Hutchings, DC
Publisher:
BMJ Publishing Group Publisher's website
Journal:
Heart Journal website
Publication date:
2016-07-26
EISSN:
1468-201X
ISSN:
1355-6037
URN:
uuid:5356c137-2406-4344-993d-084e188bfdf3
Source identifiers:
623643
Local pid:
pubs:623643

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP